Carlsson Martin, Brudin Lars, Wanby Pär
Department of Clinical Chemistry, County Hospital of Kalmar, Kalmar, Sweden.
Department of Medicine and Optometry, Linnaeus University, Kalmar, Sweden.
Eat Weight Disord. 2018 Apr;23(2):247-254. doi: 10.1007/s40519-017-0392-y. Epub 2017 Apr 28.
Anorexia nervosa (AN) is an eating disorder characterized by low fat mass complicated by osteoporosis. The role of circulating vitamin D in the development of bone loss in AN is unclear. Fat mass is known to be inversely associated with vitamin D levels measured as serum levels of total, protein-bound 25-hydroxyvitamin D, but the importance of directly measured, free levels of 25(OH)D has not been determined in AN. The aim of this study was to investigate vitamin D status, as assessed by serum concentrations of total and free serum 25(OH)D in patients with AN and healthy controls.
In female AN patients (n = 20), and healthy female controls (n = 78), total 25(OH)D was measured by LC-MS/MS, and free 25(OH)D with ELISA. In patients with AN bone mineral density (BMD) was determined with DEXA.
There were no differences between patients and controls in total or free S-25(OH)D levels (80 ± 31 vs 72 ± 18 nmol/L, and 6.5 ± 2.5 vs 5.6 ± 1.8 pg/ml, respectively), and no association to BMD was found. In the entire group of patients and controls, both vitamin D parameters correlated with BMI, leptin, and PTH.
The current study did not demonstrate a vitamin D deficiency in patients with AN and our data does not support vitamin D deficiency as a contributing factor to bone loss in AN. Instead, we observed a trend toward higher vitamin D levels in AN subjects compared to controls. Measurement of free vitamin D levels did not contribute to additional information.
神经性厌食症(AN)是一种以低脂肪量并伴有骨质疏松为特征的饮食失调症。循环维生素D在AN骨质流失发展过程中的作用尚不清楚。已知脂肪量与以血清总25-羟基维生素D、蛋白结合25-羟基维生素D水平衡量的维生素D水平呈负相关,但直接测量的游离25(OH)D水平在AN中的重要性尚未确定。本研究的目的是通过AN患者和健康对照者血清总25(OH)D和游离血清25(OH)D浓度评估维生素D状态。
在女性AN患者(n = 20)和健康女性对照者(n = 78)中,采用液相色谱-串联质谱法测定总25(OH)D,采用酶联免疫吸附测定法测定游离25(OH)D。对AN患者用双能X线吸收法测定骨密度(BMD)。
患者和对照者的总S-25(OH)D或游离S-25(OH)D水平无差异(分别为80±31 vs 72±18 nmol/L和6.5±2.5 vs 5.6±1.8 pg/ml),且未发现与BMD相关。在整个患者和对照者组中,两种维生素D参数均与体重指数、瘦素和甲状旁腺激素相关。
本研究未证实AN患者存在维生素D缺乏,我们的数据不支持维生素D缺乏是AN骨质流失的一个促成因素。相反,我们观察到与对照组相比,AN受试者的维生素D水平有升高趋势。游离维生素D水平的测量未提供更多信息。